drugset / Trial / NCT00118014

Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania

NCT00118014

Phase 4 Completed 75 enrolled Massachusetts General Hospital Pfizer · collab
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess the extent of symptom remission in patients with trichotillomania following treatment with sertraline and/or behavior therapy.

Timeline

Start
2000-01
Primary completion
2004-04
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Sertraline Small molecule